Atrial Fibrillation medical device provider AtriCure Inc. has completed its acquisition of Endoscopic Technologies Inc., doing business as Estech. Estech develops and markets a portfolio of surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures using temperature controlled RF energy.
“We are pleased to complete the acquisition of Estech, and we welcome the team to AtriCure. This transaction provides substantial benefits to AtriCure and strengthens our leadership position in the atrial fibrillation market; we are excited about the opportunities that our combined businesses will bring to our customers,” says Mike Carrel, President and Chief Executive Officer of AtriCure.
Release Date: January 2, 2014